Literature DB >> 17996944

Expression of granzyme B in peripheral blood polymorphonuclear neutrophils (PMN), myeloid cell lines and in PMN derived from haemotopoietic stem cells in vitro.

Christof Wagner1, Sabine Stegmaier, Gertrud Maria Hänsch.   

Abstract

Granzyme B and perforin are the major protagonists of cytotoxicity mediated by natural killer (NK) cells or cytotoxic T cells. More recent we described the presence of granzyme B and perforin in polymorphonuclear neutrophils (PMN), a finding in discrepancy with the credo that granzyme B and perforin expression is restricted to cytotoxic T cells and NK cells. In extension of our previous study, we now provide evidence that granzyme B is not only present in mature PMN, but also in the myeloid cell lines HL-60 and U937, in CD34+ stem cells, and in PMN derived from CD34+ cells in vitro. In agreement with the "targeting by time" hypothesis we found the bulk of granzyme B in association with primary granules, in addition to a minor membrane expression. Granzyme B, on one hand might, enhance the cytotoxic potential of PMN, on the other, it may provide PMN with additional means to degrade extracellular matrices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996944     DOI: 10.1016/j.molimm.2007.09.033

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Granzyme B-expressing neutrophils correlate with bacterial load in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques.

Authors:  Joshua T Mattila; Pauline Maiello; Tao Sun; Laura E Via; JoAnne L Flynn
Journal:  Cell Microbiol       Date:  2015-03-12       Impact factor: 3.715

2.  Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma.

Authors:  Hely Ollila; Mikko I Mäyränpää; Lassi Paavolainen; Juuso Paajanen; Katja Välimäki; Eva Sutinen; Henrik Wolff; Jari Räsänen; Olli Kallioniemi; Marjukka Myllärniemi; Ilkka Ilonen; Teijo Pellinen
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

3.  Murine myeloid derived suppressor cells possess a range of suppressive mechanisms-Granzyme B is not among them.

Authors:  Ellis Tibbs; Xuefang Cao
Journal:  Cancer Immunol Immunother       Date:  2022-02-07       Impact factor: 6.630

4.  Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm.

Authors:  Ciara M Chamberlain; Lisa S Ang; Wendy A Boivin; Dawn M Cooper; Sarah J Williams; Hongyan Zhao; Alon Hendel; Maggie Folkesson; Jesper Swedenborg; Michael F Allard; Bruce M McManus; David J Granville
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

5.  Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment.

Authors:  Amandine Martin; Cédric Seignez; Cindy Racoeur; Nicolas Isambert; Nesrine Mabrouk; Alessandra Scagliarini; Sylvie Reveneau; Laurent Arnould; Ali Bettaieb; Jean-François Jeannin; Catherine Paul
Journal:  Oncotarget       Date:  2018-06-19

6.  IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus.

Authors:  Rosanne Spolski; Erin E West; Peng Li; Sharon Veenbergen; Sunny Yung; Majid Kazemian; Jangsuk Oh; Zu-Xi Yu; Alexandra F Freeman; Stephen M Holland; Philip M Murphy; Warren J Leonard
Journal:  Elife       Date:  2019-04-16       Impact factor: 8.140

7.  Granzyme B Attenuates Bacterial Virulence by Targeting Secreted Factors.

Authors:  Diego López León; Patricia Matthey; Isabelle Fellay; Marianne Blanchard; Denis Martinvalet; Pierre-Yves Mantel; Luis Filgueira; Michael Walch
Journal:  iScience       Date:  2020-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.